{"id":"W4413370533","doi":"10.1093/nop/npaf061","title":"Dabrafenib in pediatric patients with <i>BRAF</i> V600 mutation–positive high-grade glioma: Results from a phase 1/2a single-arm study","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"Novartis Pharma; National Institute for Health and Care Research; Novartis; GlaxoSmithKline","keywords":"Dabrafenib; Glioma; Medicine; Mutation; Glioblastoma; Oncology; Internal medicine; Cancer research; Biology; Genetics; Gene; Cancer; Metastatic melanoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001638312,0.001031448,0.00179835,0.000264188,0.0002298078,0.0007712645,0.0004403736,0.0005306517,0.001015435],"category_scores_gemma":[0.0008363111,0.0003521162,0.001449315,0.0004490639,0.0004846495,0.0005126729,0.0002025421,0.001490855,0.000249108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008077268,"about_ca_system_score_gemma":0.001280839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007884668,"about_ca_topic_score_gemma":0.002637316,"domain_scores_codex":[0.9994597,0.0002759412,0.00004806274,0.00007091718,0.00007116453,0.00007433716],"domain_scores_gemma":[0.9993691,0.0001156241,0.0001927806,0.00004989318,0.00007031277,0.0002023171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4126588,0.03862569,0.1217054,0.00432127,0.01390035,0.001748014,0.0009634832,0.006993261,0.09048525,0.0007136504,0.01098847,0.2968963],"study_design_scores_gemma":[0.2982924,0.5005991,0.1556766,0.0003023554,0.007853254,0.003775723,0.0002997068,0.002461745,0.01499352,0.0004555879,0.01517801,0.0001119897],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860125,0.009946099,0.000671041,0.0002727774,0.00004286657,0.0008797536,0.001140024,0.00005139109,0.0009834766],"genre_scores_gemma":[0.9876192,0.007362762,0.001522885,0.0005300383,0.00009507246,0.0008440848,0.001574578,0.00001692478,0.0004344809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00179835,"threshold_uncertainty_score":0.00866431,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0164763583988484,"score_gpt":0.3175267917357269,"score_spread":0.3010504333368785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}